case based panel discussion - rapid progression adenocarcinoma high pd-l1 - how do you treat?
Published 5 years ago • 155 plays • Length 8:17Download video MP4
Download video MP3
Similar videos
-
6:17
case based panel discussion –alk positive, high pd-l1:first line treatment for competing targets
-
5:06
case based panel discussion - egfr mutation and high pdl1 - what is the role of immunotherapy in tre
-
4:14
case based panel discussion - egfr and high pdl1 what is the role of immunotherapy in treatment?
-
9:07
case based panel discussion - adv non squamous nsclc, high pd-l1, no mutation - optimal 1st line?
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
8:36
case study: mutation-negative patient with lung adenocarcinoma
-
43:39
dec23 - cbdc technological choices (panel discussion)
-
7:01
case based panel discussion 2.6 alk positive and high pdl1 first line treatment for potentially comp
-
8:18
case based panel discussion - egfr and high pdl-1, choosing targeted therapy or immunotherapy
-
7:12
egfr mutated adenocarcinoma - case based panel discussions
-
6:30
stage 3 squamous lung cancer with low pd-l1 - case based panel discussion
-
9:21
case based panel discussions - metastatic squamous nsclc low tumor pd-l1 frail patient - treatment?
-
12:59
case based panel discussion - adv non squamous nsclc, low pd-l1 no mutation - best systemic therapy?
-
13:00
stage 3a node-positive lung adenocarcinoma with alk rearrangement - case based panel discussions
-
4:10
how oncologists stage disease - case based panel discussion
-
11:09
case based panel discussion - fit patient adv squamous nsclc low tumor pd-l1
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
5:04
case based panel discussion - egfr: oligoprogression brain &/or body vs. worsening progression
-
2:14
is there a role for pd l1 testing after first line treatment for advanced non small cell lung cancer
-
9:59
case based panel discussions - alk positive, developing resistance to alk inhibitors and next steps
-
2:02
what is the role for pd l1 testing for adv.nsclc in initial diagnosis